Literature DB >> 34669950

Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation.

Sophia Huang1, Payam Safavi-Naeini2, Abdi Rasekh1.   

Abstract

Entities:  

Keywords:  Anticoagulants/administration & dosage/therapeutic use; atrial appendage/therapy; atrial fibrillation/complications/therapy; factor Xa inhibitors; left atrial appendage/ligation; non-vitamin K antagonist oral anticoagulants; stroke/prevention & control/treatment outcome

Mesh：

Substances：

Year:  2021        PMID： 34669950      PMCID： PMC8717747          DOI： 10.14503/THIJ-21-7549

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  23 in total

1.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

2.  What's New in Anticoagulation.

Authors:  Joanna Esther Molina Razavi; Payam Safavi-Naeini; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2016-10-01

3.  Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.

Authors:  Xavier Freixa; Laura Llull; Sameer Gafoor; Ignacio Cruz-Gonzalez; Samera Shakir; Heyder Omran; Sergio Berti; Gennaro Santoro; Joelle Kefer; Ulf Landmesser; Jens Erik Nielsen-Kudsk; Prapa Kanagaratnam; Fabian Nietlispach; Steffen Gloekler; Adel Aminian; Paolo Danna; Marco Rezzaghi; Friederike Stock; Miroslava Stolcova; Luis Paiva; Marco Costa; Xavier Millán; Reda Ibrahim; Tobias Tichelbäcker; Wolfgang Schillinger; Jai-Wun Park; Horst Sievert; Bernhard Meier; Apostolos Tzikas
Journal:  Am J Cardiol       Date:  2016-09-15       Impact factor: 2.778

Review 4.  Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.

Authors:  Hooman Kamel; Peter M Okin; Mitchell S V Elkind; Costantino Iadecola
Journal:  Stroke       Date:  2016-01-19       Impact factor: 7.914

5.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

6.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.

Authors:  Vivek Y Reddy; Shephal K Doshi; Saibal Kar; Douglas N Gibson; Matthew J Price; Kenneth Huber; Rodney P Horton; Maurice Buchbinder; Petr Neuzil; Nicole T Gordon; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2017-11-04       Impact factor: 24.094

Review 9.  New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.

Authors:  Ymer H Mekaj; Agon Y Mekaj; Shkelzen B Duci; Ermira I Miftari
Journal:  Ther Clin Risk Manag       Date:  2015-06-24       Impact factor: 2.423

10.  NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis.

Authors:  Tim Hicks; Fiona Stewart; Anne Eisinga
Journal:  Open Heart       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.